CIK 0001022899
- Non-accelerated filer
- Smaller reporting company
Protagenic Therapeutics, Inc.\new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061390025
- Phone
- +1 212-994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-25 | Arrow Alexander K. Chief Financial Officer | Grant or award · PTIX Common stock Options | +100,000 | $1.74 | $174K | 100,000 |
| 2023-10-12 | Arrow Alexander K. Chief Financial Officer | Purchase | +8,000 | $0.81 | $6K | 45,815 |
| 2022-05-18 | Arrow Alexander K. Chief Financial Officer | Purchase | +8,000 | $0.72 | $6K | 151,260 |
| 2022-05-17 | Arrow Alexander K. Chief Financial Officer | Purchase | +23,000 | $0.71 | $16K | 143,260 |
| 2021-06-03 | Arrow Alexander K. Chief Financial Officer | Purchase · PTIXW Common Stock 5-year warrants strike price $4.98 | +16,900 | $0.38 | $6K | 50,000 |
| 2021-06-02 | Arrow Alexander K. Chief Financial Officer | Purchase · PTIXW Common Stock 5-year warrants strike price $4.98 | +100 | $0.38 | $38 | 33,100 |
| 2021-05-27 | Arrow Alexander K. Chief Financial Officer | Purchase · PTIXW Common Stock 5-year warrants strike price $4.98 | +3,000 | $0.38 | $1K | 33,000 |
| 2021-05-18 | Arrow Alexander K. Chief Financial Officer | Purchase · PTIXW Common Stock 5-year warrants strike price $4.98 | +12,000 | $0.32 | $4K | 12,000 |
| 2021-05-18 | Arrow Alexander K. Chief Financial Officer | Purchase · PTIXW Common Stock 5-year warrants strike price $4.98 | +18,000 | $0.31 | $6K | 30,000 |
| 2021-04-30 | Arrow Alexander K. Chief Financial Officer | Purchase | +1,000 | $2.29 | $2K | 120,260 |
| 2021-04-29 | Arrow Alexander K. Chief Financial Officer | Purchase | +1,000 | $2.29 | $2K | 119,260 |
| 2020-07-18 | Arrow Alexander K. Chief Financial Officer | Grant or award · PTIX Common stock Options | +124,998 | $1.75 | $219K | 124,998 |
| 2020-02-21 | Arrow Alexander K. Chief Financial Officer | Grant or award · PTIX Common stock Options | +307,497 | 307,497 | ||
| 2019-03-20 | Arrow Alexander K. Chief Financial Officer | Grant or award · PTIX Common stock Options | +41,667 | 41,667 | ||
| 2017-10-16 | Arrow Alexander K. Chief Financial Officer | Grant or award · Non-Qualified Stock Options (Right to Buy) | +75,000 | 75,000 | ||
| 2016-06-17 | Arrow Alexander K. Chief Financial Officer | Grant or award | +140,000 | $1.25 | $175K | 358,260 |
| 2016-04-15 | Arrow Alexander K. Chief Financial Officer | Purchase · Series B Preferred Stock | +40,000 | $1.25 | $50K | 100,000 |
| 2016-04-15 | Arrow Alexander K. Chief Financial Officer | Purchase · Series B Preferred Stock | +18,260 | $1.25 | $23K | 118,260 |
Page 1 of 1 · 18 trades